查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1668158

運動醫學血液生物標記市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、地區和競爭細分，2020-2030 年預測

Blood-based Biomarker For Sports Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球血液運動醫學生物標記市場價值為 7.5845 億美元，預計到 2030 年將達到 10.5772 億美元，預測期內複合年成長率為 5.66%。隨著醫療診斷技術的進步推動對個人化和精準運動員護理的需求，全球基於血液的運動醫學生物標記市場正在快速成長。以血液為基礎的生物標記因其能夠即時了解運動員的生理狀況、受傷風險和恢復進度而成為運動醫學領域的熱門話題。這些生物標記包括蛋白質、代謝物和基因標記，為監測運動表現和健康的各個方面提供了一種非侵入性和客觀的手段。市場成長的主要驅動力之一是運動相關傷害的發生率不斷增加。隨著職業運動員和業餘運動員力爭達到最佳表現，肌肉拉傷、韌帶撕裂和腦震盪等傷害變得很常見。血液中的生物標記能夠早期發現組織損傷、發炎和壓力相關的狀況，從而及時採取干涉措施，促進康復並防止進一步的併發症。此外，對個人化運動醫學的日益重視推動了這些生物標記的採用，因為它們能夠根據個人獨特的生理反應制定個人化的訓練和復健計劃。

市場概況
預測期 2026-2030
2024 年市場規模 7.5845 億美元
2030 年市場規模 10.5772億美元
2025-2030 年複合年成長率 5.66%
成長最快的領域 肌酸激酶 (CK)
最大的市場 北美洲

生物技術和生物標記發現的進步也推動了市場的發展。對新型生物標記的持續研究擴大了可測量參數的範圍，從肌酸激酶（CK）和乳酸脫氫酶（LDH）等肌肉損傷指標到C反應蛋白（CRP）和白細胞介素等氧化壓力和發炎標記。這些創新不僅提高了診斷的準確性，而且還透過穿戴式和即時檢測設備實現即時監控，進一步推動市場需求。

主要市場促進因素

運動傷害增多，需要早期發現

主要市場趨勢

技術進步

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：COVID-19 對全球運動醫學血液生物標記市場的影響

第 5 章：全球基於血液的運動醫學生物標記市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按類型（CK、肌紅蛋白、乳酸、白血球、尿素、CRP、脂質和蛋白質氫過氧化物、IL-6、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第 6 章：北美運動醫學血液生物標記物市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 墨西哥
    • 加拿大

第 7 章：歐洲運動醫學血液生物標記市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區運動醫學血液生物標記市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 印度
    • 韓國
    • 日本
    • 澳洲

第 9 章：南美洲運動醫學血液生物標記物市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲運動醫學血液生物標記市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如果有）
  • 最新動態

第 13 章：全球運動醫學血液生物標記市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Abbott Laboratories
  • BIOMERIEUX
  • F. Hoffmann-La Roche Ltd.
  • ARUP Laboratories Inc.
  • Siemens Healthineers AG
  • RayBiotech, Inc
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc
  • Beckman Coulter, Inc.
  • Randox Laboratories Ltd.

第 16 章：策略建議

第17章 關於出版商,免責事項

簡介目錄
Product Code: 27717

Global Blood-based Biomarker For Sports Medicine Market was valued at USD 758.45 Million in 2024 and is expected to reach USD 1057.72 Million by 2030 with a CAGR of 5.66% during the forecast period. The global blood-based biomarker market for sports medicine is experiencing rapid growth as advancements in medical diagnostics drive the demand for personalized and precise athlete care. Blood-based biomarkers have gained traction in the field of sports medicine due to their ability to provide real-time insights into an athlete's physiological status, injury risks, and recovery progress. These biomarkers, which include proteins, metabolites, and genetic markers, offer a non-invasive and objective means of monitoring various aspects of athletic performance and health. One of the primary drivers of market growth is the increasing incidence of sports-related injuries. As professional and amateur athletes strive for peak performance, injuries such as muscle strains, ligament tears, and concussions have become common. Blood-based biomarkers enable early detection of tissue damage, inflammation, and stress-related conditions, allowing for timely interventions that can enhance recovery and prevent further complications. Additionally, the growing emphasis on personalized sports medicine has fueled the adoption of these biomarkers, as they enable tailored training and rehabilitation plans based on an individual's unique physiological responses.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 758.45 Million
Market Size 2030USD 1057.72 Million
CAGR 2025-20305.66%
Fastest Growing SegmentCreatine Kinase (CK)
Largest MarketNorth America

Advancements in biotechnology and biomarker discovery have also propelled the market forward. Continuous research into novel biomarkers has expanded the range of measurable parameters, from muscle damage indicators like creatine kinase (CK) and lactate dehydrogenase (LDH) to markers of oxidative stress and inflammation, such as C-reactive protein (CRP) and interleukins. These innovations are not only improving diagnostic accuracy but also facilitating real-time monitoring through wearable and point-of-care testing devices, further driving market demand.

Key Market Drivers

Rising Sports Injuries and Need for Early Detection

The increasing incidence of sports injuries across all levels of athletic participation is a major driver for the global blood-based biomarker for the sports medicine market. Athletes, both professional and amateur, are experiencing rising cases of muscle tears, ligament injuries, concussions, and stress fractures due to the growing intensity and competitiveness in sports. Traditional diagnostic methods, such as imaging techniques and physical assessments, often fail to detect early signs of damage, leading to delayed treatment and prolonged recovery periods. This has fueled the demand for blood-based biomarkers, which offer a minimally invasive and highly accurate means of detecting physiological and biochemical changes associated with sports-related injuries. According to the National Safety Council, in 2023, approximately 3.7 million individuals received emergency medical treatment for injuries related to sports and recreational equipment. The activities most commonly linked to these injuries include exercise, cycling, and basketball. One of the key advantages of blood-based biomarkers in sports medicine is their ability to provide early detection of injuries such as concussions and muscle damage. Biomarkers such as creatine kinase (CK), myoglobin, and C-reactive protein (CRP) can indicate muscle stress, inflammation, and tissue breakdown, allowing medical professionals to intervene before severe damage occurs. In addition, neuro biomarkers like S100 calcium-binding protein B (S100B) and tau protein are gaining attention for their role in detecting mild traumatic brain injuries (TBIs) in athletes, particularly in contact sports such as football, boxing, and rugby. The ability of these biomarkers to detect even subtle injuries has increased their adoption in sports medicine, as they facilitate personalized treatment plans and prevent long-term complications.

Key Market Trends

Technological Advancements

The blood-based biomarker for sports medicine market is witnessing significant growth, driven primarily by advancements in technology. These innovations are reshaping how biomarkers are detected, analyzed, and utilized in sports medicine to enhance athlete performance, injury prevention, and recovery monitoring. With the integration of cutting-edge diagnostic tools, artificial intelligence (AI), and wearable biosensors, the landscape of sports medicine is undergoing a transformation, making blood-based biomarkers more efficient and accessible. One of the major breakthroughs in this field is the development of high-sensitivity detection techniques, such as next-generation sequencing (NGS), mass spectrometry, and microfluidic platforms. These technologies have enhanced the precision of biomarker identification, allowing for early detection of muscle fatigue, inflammation, and potential injuries. NGS, for instance, enables comprehensive genomic and proteomic analysis from small blood samples, providing detailed insights into an athlete's physiological state. Similarly, mass spectrometry has improved the accuracy of biomarker quantification, leading to more reliable assessments of biochemical changes associated with sports-related stress and injuries.

Key Market Players

  • Abbott Laboratories
  • BIOMERIEUX
  • F. Hoffmann-La Roche Ltd.
  • ARUP Laboratories Inc.
  • Siemens Healthineers AG
  • RayBiotech, Inc
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc
  • Beckman Coulter, Inc.
  • Randox Laboratories Ltd.

Report Scope

In this report, the Global Blood-based Biomarker For Sports Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood-based Biomarker For Sports Medicine Market, By Type:

  • CK
  • Myoglobin
  • Lactate
  • WBC
  • Urea
  • CRP
  • Lipid and Protein Hydroperoxides
  • IL-6
  • Others

Blood-based Biomarker For Sports Medicine Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood-based Biomarker For Sports Medicine Market.

Available Customizations:

Global Blood-based Biomarker For Sports Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Blood-based Biomarker For Sports Medicine Market

5. Global Blood-based Biomarker For Sports Medicine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6, Others)
    • 5.2.2. By Region
    • 5.2.3. By Company (2024)
  • 5.3. Market Map

6. North America Blood-based Biomarker For Sports Medicine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood-based Biomarker For Sports Medicine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
    • 6.3.2. Mexico Blood-based Biomarker For Sports Medicine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
    • 6.3.3. Canada Blood-based Biomarker For Sports Medicine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End Use

7. Europe Blood-based Biomarker For Sports Medicine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
    • 7.3.2. Germany Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
    • 7.3.3. United Kingdom Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
    • 7.3.4. Italy Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
    • 7.3.5. Spain Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type

8. Asia Pacific Blood-based Biomarker For Sports Medicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
    • 8.3.2. India Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
    • 8.3.3. South Korea Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
    • 8.3.4. Japan Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
    • 8.3.5. Australia Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type

9. South America Blood-based Biomarker For Sports Medicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Blood-based Biomarker For Sports Medicine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
    • 9.3.2. Argentina Blood-based Biomarker For Sports Medicine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
    • 9.3.3. Colombia Blood-based Biomarker For Sports Medicine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type

10. Middle East and Africa Blood-based Biomarker For Sports Medicine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Blood-based Biomarker For Sports Medicine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
    • 10.3.2. Saudi Arabia Blood-based Biomarker For Sports Medicine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
    • 10.3.3. UAE Blood-based Biomarker For Sports Medicine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Blood-based Biomarker For Sports Medicine Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Abbott Laboratories
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. BIOMERIEUX
  • 15.3. F. Hoffmann-La Roche Ltd.
  • 15.4. ARUP Laboratories Inc.
  • 15.5. Siemens Healthineers AG
  • 15.6. RayBiotech, Inc
  • 15.7. Thermo Fisher Scientific, Inc.
  • 15.8. Bio-Rad Laboratories, Inc
  • 15.9. Beckman Coulter, Inc.
  • 15.10. Randox Laboratories Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer